Ranking Profile - Beam Therapeutics Inc

Introduction

Beam Therapeutics Inc (Beam Therapeutics) is a biotechnology company. The company develops precision genetic medicines to treat serious genetic diseases. It is investigating BEAM-101 targeting sickle cell disease and beta-thalassemia, BEAM-102 against sickle cell disease and BEAM-201 for the treatment of T-cell acute lymphoblastic leukemia. Beam Therapeutics is also evaluating therapies against acute myeloid leukemia, alpha 1 antitrypsin deficiency, glycogen storage disorder 1a and Stargardt disease. It utilizes the REPAIR system for A-to-I (adenosine to inosine) RNA (Ribonucleic acid) editing and RESCUE system for C-to-U (cytidine to uridine) RNA editing. Beam Therapeutics is headquartered in Cambridge, Massachusetts, the US.